Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed May 11, 2023 · 10-Q · 41 days after period end · 0001640334-23-000804
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$2.17M | -$1.97M | -$1.70M | -$556.90K |
| EPS Diluted | — | — | — | -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 11, 2023 · 41 d after period end
